• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓展视野:扩大免疫规划中增加可注射疫苗

Expanding Horizons: Increasing Injectable Vaccine in the Expanded Program on Immunization.

作者信息

Gupta Birendra Prasad, Ghimire Namita

机构信息

Virology Society Nepal, Kathmandu, Nepal.

Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal.

出版信息

JNMA J Nepal Med Assoc. 2024 Nov;62(279):785-788. doi: 10.31729/jnma.8773. Epub 2024 Nov 30.

DOI:10.31729/jnma.8773
PMID:40656802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931338/
Abstract

The World Health Organization started the Expanded Program on Immunization in 1974, including 6 antigens with up to 8 vaccine doses for childhood vaccination. The number of antigens has now increased to 11 antigens in 21 vaccines. The expansion of vaccination programs to include more antigens and doses has led to concerns about the burden of multiple injections on infants and children, as well as factors such as fear of adverse reactions, pain, and overall acceptability of vaccines. To address these challenges, there's a call for research to focus on developing combined vaccines that can be administered through more acceptable routes, such as oral, nasal, or needleless administration. This approach could potentially reduce the number of injections required and increase the willingness of individuals to receive vaccines. We highlight the importance of ongoing research and innovation in vaccine development and delivery methods to ensure that vaccination programs remain effective, efficient, and acceptable to the communities they serve, particularly in resource-limited settings.

摘要

世界卫生组织于1974年启动了扩大免疫规划,其中包括6种抗原,儿童接种疫苗最多可达8剂。目前,抗原数量已增加到21种疫苗中的11种抗原。疫苗接种计划的扩大,纳入了更多的抗原和剂量,这引发了人们对婴幼儿多次注射负担的担忧,以及对诸如害怕不良反应、疼痛和疫苗总体可接受性等因素的关注。为应对这些挑战,人们呼吁开展研究,重点是开发可通过更易接受的途径(如口服、鼻内或无针给药)接种的联合疫苗。这种方法有可能减少所需的注射次数,并提高个人接种疫苗的意愿。我们强调在疫苗研发和给药方法方面持续进行研究和创新的重要性,以确保疫苗接种计划对其服务的社区仍然有效、高效且可接受,特别是在资源有限的环境中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d961/11931338/422a5902ac9a/JNMA-62-279-785-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d961/11931338/e8c4cbd6a53f/JNMA-62-279-785-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d961/11931338/422a5902ac9a/JNMA-62-279-785-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d961/11931338/e8c4cbd6a53f/JNMA-62-279-785-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d961/11931338/422a5902ac9a/JNMA-62-279-785-g2.jpg

相似文献

1
Expanding Horizons: Increasing Injectable Vaccine in the Expanded Program on Immunization.拓展视野:扩大免疫规划中增加可注射疫苗
JNMA J Nepal Med Assoc. 2024 Nov;62(279):785-788. doi: 10.31729/jnma.8773. Epub 2024 Nov 30.
2
Needle size for vaccination procedures in children and adolescents.儿童和青少年疫苗接种程序的针头尺寸。
Cochrane Database Syst Rev. 2015 Jun 18(6):CD010720. doi: 10.1002/14651858.CD010720.pub2.
3
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.1980年至2023年全球、区域和国家儿童常规疫苗接种覆盖率趋势及2030年预测:2023年全球疾病负担研究的系统分析
Lancet. 2025 Jun 24. doi: 10.1016/S0140-6736(25)01037-2.
4
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.父母及非正式照料者关于儿童常规疫苗接种沟通的观点与经历:定性证据综述
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Vaccines for preventing infections in adults with haematological malignancies.用于预防血液系统恶性肿瘤成人感染的疫苗。
Cochrane Database Syst Rev. 2025 May 21;5(5):CD015530. doi: 10.1002/14651858.CD015530.pub2.
7
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
8
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
9
Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.低收入和中等收入国家疫苗瓶监测器的可及性与使用情况:一项系统评价
Vaccine. 2017 Apr 19;35(17):2155-2161. doi: 10.1016/j.vaccine.2016.11.102.
10
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)联合疫苗与分别接种白喉、破伤风、百日咳、乙型肝炎疫苗和HIB疫苗用于白喉、破伤风、百日咳、乙型肝炎和B型流感嗜血杆菌(HIB)的一级预防。
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD005530. doi: 10.1002/14651858.CD005530.pub3.

本文引用的文献

1
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.伤寒结合疫苗(Vi-DT)的安全性和免疫原性:来自一项针对健康志愿者的观察者盲法、活性对照、随机、非劣效性III期临床试验的结果。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2301631. doi: 10.1080/21645515.2023.2301631. Epub 2024 Jan 8.
2
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.9-15 月龄尼泊尔婴儿接种含麻疹、腮腺炎和风疹疫苗的 Vi-DT 伤寒结合疫苗的免疫非干扰和安全性研究。
Vaccine. 2022 Sep 22;40(40):5828-5834. doi: 10.1016/j.vaccine.2022.08.034. Epub 2022 Sep 3.
3
Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal.影响欠发达国家疫苗临床试验参与意愿的因素:来自尼泊尔的观点。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2051413. doi: 10.1080/21645515.2022.2051413. Epub 2022 Mar 30.
4
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.在尼泊尔健康志愿者中 Vi-DT 伤寒结合疫苗的安全性和免疫原性:一项观察者盲法、主动对照、随机、非劣效性、3 期临床试验。
Lancet Infect Dis. 2022 Apr;22(4):529-540. doi: 10.1016/S1473-3099(21)00455-2. Epub 2021 Dec 20.
5
Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal.在资源有限的环境中开展三期疫苗临床试验的挑战与机遇:来自尼泊尔的经验
Hum Vaccin Immunother. 2021 Jul 3;17(7):2149-2157. doi: 10.1080/21645515.2020.1855955. Epub 2021 Feb 1.
6
Incomplete Vaccination and Its Predictors among Children in Ethiopia: A Systematic Review and Meta-Analysis.埃塞俄比亚儿童的疫苗接种不完整情况及其预测因素:一项系统评价与荟萃分析
Glob Pediatr Health. 2020 Oct 30;7:2333794X20968681. doi: 10.1177/2333794X20968681. eCollection 2020.
7
Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.尼泊尔 HIV 感染人群中乙型肝炎病毒和/或丙型肝炎病毒感染的流行病学特征和危险因素。
Biomed Res Int. 2018 Jan 2;2018:9241679. doi: 10.1155/2018/9241679. eCollection 2018.
8
Dengue periodic outbreaks and epidemiological trends in Nepal.尼泊尔登革热的周期性暴发和流行趋势。
Ann Clin Microbiol Antimicrob. 2018 Feb 23;17(1):6. doi: 10.1186/s12941-018-0258-9.
9
Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women.尼泊尔女性宫颈癌活检组织中人乳头瘤病毒基因型分布情况
Infect Agent Cancer. 2018 Jan 17;13:4. doi: 10.1186/s13027-018-0176-7. eCollection 2018.
10
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.麻疹和风疹全球战略计划 2012-2020 年中期审查报告:背景和摘要。
Vaccine. 2018 Jan 11;36 Suppl 1:A35-A42. doi: 10.1016/j.vaccine.2017.10.065.